1. People's Republic of China Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
Hainan Poly Pharm. Co., Ltd

Hainan Poly Pharm. Co., Ltd

300630.SZ
Hainan Poly Pharm. Co., LtdCN flagShenzhen Stock Exchange
0.89
CNY
+0.01
- -
499.57MMarket Cap

Total Valuation

Hainan Poly Pharm. Co., Ltd carries a market capitalization of 499.57M, placing it among publicly traded companies globally. Its enterprise value stands at 7.43B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap499.57M
Enterprise Value7.43B

Share Statistics

Hainan Poly Pharm. Co., Ltd currently has 451.78M shares outstanding.

Shares Outstanding451.78M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

Hainan Poly Pharm. Co., Ltd trades at a trailing price-to-earnings ratio of 52.12. The price-to-sales ratio is 3.86, and the price-to-book ratio stands at 3.12.

PE Ratio52.12
PS Ratio3.86
PB Ratio3.12
P/TBV Ratio2.58
P/FCF Ratio43.46
P/OCF RatioN/A

Enterprise Valuation

On an enterprise value basis, Hainan Poly Pharm. Co., Ltd trades at an EV/EBITDA multiple of 74.46 and an EV/FCF ratio of 159.58. The EV/Sales ratio of 5.69 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 74.46 provides insight into valuation relative to core operating earnings.

EV / Sales5.69
EV / EBITDA74.46
EV / EBIT74.46
EV / FCF159.58

Financial Position

Hainan Poly Pharm. Co., Ltd maintains a current ratio of 1.56, meaning it holds 1.6x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 96.76, indicating elevated leverage, while an interest coverage ratio of 3.12 demonstrates adequate ability to service its debt obligations.

Current Ratio1.56
Quick Ratio0.24
Debt / Equity96.76
Debt / EBITDA27.24
Interest Coverage3.12

Financial Efficiency

Hainan Poly Pharm. Co., Ltd posts a return on equity of -6.34 and a return on invested capital of -19.26.

Return on Equity (ROE)-6.34
Return on Assets (ROA)-1.69
Return on Invested Capital (ROIC)-19.26
Return on Capital Employed (ROCE)-10.12
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover0.71

Taxes

Over the trailing twelve months, Hainan Poly Pharm. Co., Ltd has paid 116.20M in income taxes, reflecting an effective tax rate of 1,143.31.

Income Tax116.20M
Effective Tax Rate1,143.31

Stock Price Statistics

Hainan Poly Pharm. Co., Ltd's stock has declined approximately -90.9919% over the past 52 weeks. The 50-day moving average sits at 1.85, while the 200-day moving average is 6.04.

Beta (5Y)N/A
52-Week Price Change-90.9919%
50-Day Moving Average1.85
200-Day Moving Average6.04
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Hainan Poly Pharm. Co., Ltd generated 1.31B in revenue and converted that into -106.04M in net income, yielding earnings per share of -0.22. EBITDA reached 99.77M, while operating income came in at 99.77M.

Revenue1.31B
Gross Profit941.39M
Operating Income99.77M
Pretax Income10.16M
Net Income-106.04M
EBITDA99.77M
EBIT99.77M
Earnings Per Share (EPS)-0.22

Balance Sheet

Hainan Poly Pharm. Co., Ltd holds 331.37M in cash and equivalents against 2.72B in total debt, resulting in a net debt position of 1.84B. Total book value stands at 1.61B, with working capital of 784.27M providing operational flexibility.

Cash & Cash Equivalents331.37M
Total Debt2.72B
Net Debt1.84B
Equity (Book Value)1.61B
Book Value Per Share3.63
Working Capital784.27M

Cash Flow

After subtracting -124.30M in capital expenditures, free cash flow totaled -124.30M - equivalent to -0.28 per share.

Operating Cash FlowN/A
Capital Expenditures-124.30M
Free Cash Flow-124.30M
FCF Per Share-0.28

Margins

Hainan Poly Pharm. Co., Ltd operates with a gross margin of 72.05, reflecting its pricing power and cost economics. The operating margin of 7.64 and net profit margin of -8.12 provide insight into operational efficiency.

Gross Margin72.05
Operating Margin7.64
Pretax Margin0.78
Profit Margin-8.12
EBITDA Margin7.64

Dividends & Yields

The company's payout ratio of -69.43 indicates the proportion of earnings distributed to shareholders.

Dividend Per Share0.17
Dividend YieldN/A
Payout Ratio-69.43
Shareholder Yield-1.87
FCF Yield2.30

Stock Splits

Hainan Poly Pharm. Co., Ltd's most recent stock split took place on July 3, 2020 with a 40000:61287 split ratio.

Last Split Date7/3/2020
Split Ratio40000:61287

Scores

Hainan Poly Pharm. Co., Ltd posts an Altman Z-Score of 1.66, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score1.66